Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)
China flag China · Delayed Price · Currency is CNY
31.68
-0.17 (-0.53%)
Nov 13, 2024, 3:00 PM CST

Hubei Jumpcan Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
29,20028,97225,09225,17317,96919,705
Upgrade
Market Cap Growth
14.52%15.46%-0.32%40.09%-8.81%-27.88%
Upgrade
Enterprise Value
18,74919,71118,86520,55614,63318,236
Upgrade
Last Close Price
31.6830.3125.4625.7417.9420.28
Upgrade
PE Ratio
10.469.8410.6513.4811.7310.19
Upgrade
PS Ratio
3.263.002.793.302.912.84
Upgrade
PB Ratio
2.062.172.212.762.313.23
Upgrade
P/FCF Ratio
13.679.1610.5615.2913.2912.31
Upgrade
P/OCF Ratio
12.328.369.5713.2910.099.17
Upgrade
EV/Sales Ratio
2.102.042.102.692.372.63
Upgrade
EV/EBITDA Ratio
6.236.207.3710.478.788.96
Upgrade
EV/EBIT Ratio
6.906.848.3712.3010.5610.12
Upgrade
EV/FCF Ratio
8.786.237.9412.4910.8211.39
Upgrade
Debt / Equity Ratio
0.090.080.040.070.080.09
Upgrade
Debt / EBITDA Ratio
0.410.340.160.320.360.28
Upgrade
Debt / FCF Ratio
0.570.340.170.380.450.36
Upgrade
Asset Turnover
0.510.580.660.670.640.84
Upgrade
Inventory Turnover
2.864.054.013.903.663.38
Upgrade
Quick Ratio
3.542.993.132.753.182.47
Upgrade
Current Ratio
3.723.103.262.903.342.67
Upgrade
Return on Equity (ROE)
20.97%22.87%21.20%20.33%18.42%28.07%
Upgrade
Return on Assets (ROA)
9.78%10.88%10.39%9.22%9.03%13.69%
Upgrade
Return on Capital (ROIC)
11.86%13.75%13.10%11.52%11.51%17.75%
Upgrade
Earnings Yield
9.56%9.74%8.65%6.83%7.11%8.24%
Upgrade
FCF Yield
7.32%10.91%9.47%6.54%7.52%8.13%
Upgrade
Dividend Yield
4.08%4.29%3.46%2.64%2.51%6.07%
Upgrade
Payout Ratio
43.91%29.16%27.89%23.81%78.98%61.94%
Upgrade
Buyback Yield / Dilution
0.20%-0.91%-0.91%-7.82%-2.36%-0.02%
Upgrade
Total Shareholder Return
4.28%3.38%2.55%-5.18%0.15%6.05%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.